A similar approach was used in neonatal stroke and development using bi-transgenic CCR2-CreERtg/+; R26R-EGFPtg/+ mice, where Ly6Chi and Ly6Clo cells could be mapped despite downregulation of CCR2 (9). The gene discussed is CCR2; the disease is Stroke.